Pulmonx (LUNG) Accounts Payables (2019 - 2025)

Pulmonx (LUNG) has reported Accounts Payables for 7 consecutive years, with $3.9 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Accounts Payables rose 2.04% year-over-year to $3.9 million in Q4 2025; TTM through Dec 2025 was $3.9 million, a 2.04% increase from a year earlier, with the FY2025 full-year figure at $3.9 million, up 2.04% from the prior year.
• Accounts Payables was $3.9 million for Q4 2025 at Pulmonx, down from $6.4 million in the prior quarter.
• Over five years, Accounts Payables peaked at $6.6 million in Q2 2025 and troughed at $1.5 million in Q4 2023.
• A 5-year average of $3.3 million and a median of $3.0 million in 2023 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables tumbled 40.28% in 2022 and surged 155.64% in 2024, its largest moves.
• Over 5 years, Accounts Payables stood at $1.6 million in 2021, then gained by 11.13% to $1.8 million in 2022, then fell by 14.85% to $1.5 million in 2023, then surged by 155.64% to $3.8 million in 2024, then increased by 2.04% to $3.9 million in 2025.
• The last three Accounts Payables figures came in at $3.9 million (Q4 2025), $6.4 million (Q3 2025), and $6.6 million (Q2 2025), per Business Quant data.